Reid IR and Ibbertson HK. Calcium supplements in the prevention of steroid-induced osteoporosis.
Am J Clin Nutr
44(2): 287 - 290, 1986.
Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis.
Cochrane Database Syst Rev
(2): CD000952, 2000.
Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D
3
supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med
125: 961 - 968, 1996.
Davis RH, Parker WL, and Murdoch DP.
Aloe vera
as a biologically active vehicle for hydrocortisone acetate.
J Am Podiatric Med Assoc
81: 1 - 9, 1991.
Teelucksingh S, Mackie ADR, Burt D, et al. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid.
Lancet
335: 1060 - 1063, 1990.
Tamura Y, Nishikawa T, Yamada K, et al. Effects of glycyrrhetinic acid and its derivatives on delta-4-5-alpha- and 5-beta-reductase in rat liver.
Arzneimittelforschung
29: 647 - 649, 1979.
Chen MF, Shimada F, Kato H, et al. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate.
Endocrinol Jpn
37: 331 - 341, 1990.
Kumagai A, Nanaboshi M, Asanuma Y, et al. Effects of glycyrrhizin on thymolytic and immunosuppressive action of cortisone.
Endocrinol Jpn
14: 39 - 42, 1967.
Robinzon B and Cutulo M. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids?
Rheumatology
38: 488 - 495, 1999.
van Vollenhoven RF, Park JL, Genovese MC, et al. A double-blind, placebo-controlled, clinical trial of dehydroepianodrosterone in severe systemic lupus erythematosus.
Lupus
8(3): 181 - 187, 1999.
Ravina A, Slezak L, Mirsky N, et al. Reversal of corticosteroid-induced diabetes mellitis with supplemental chromium.
Diabet Med
16: 164 - 167, 1999.
Ravina A, Slezak L, Mirsky N, et al. Control of steroid-induced diabetes with supplemental chromium.
J Trace Elem Exp Med
12: 375 - 378, 1999.
Agnusdei D and Bufalino L. Efficacy of ipriflavone in established osteoporosis and long-term safety.
Calcif Tissue Int
61(suppl 1): S23 - S27, 1997.
Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
JAMA
285: 1482 - 1488, 2001.
Roy BD, Bourgeois JM, Mahoney DJ, et al. Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats.
Can J Physiol Pharmacol. 2002;80:1008 - 1014.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.